eliquis apixaban eliquis apixaban eliquis apixaban

This information is intended for healthcare professionals based in the UK.

If you are not a healthcare professional in the UK, click here.

For Prescribing and Adverse Event reporting information, click here.

eliquis (apixaban) a factor xa inhibitor image 2 LEARN MORE eliquis (apixaban) a factor xa inhibitor image 5 LEARN MORE

Purple information icon ELIQUIS (apixaban) SmPC

Please click here to access the ELIQUIS SmPC.

Purple information icon ELIQUIS (apixaban) Patient Information Leaflet

Please click here to access the ELIQUIS Patient Information Leaflet.

DVT = Deep Vein Thrombosis   
NVAF = Non-Valvular Atrial Fibrillation   
PE = Pulmonary Embolism   
SmPC = Summary of Product Characteristics

ELIQUIS (apixaban) is an oral, direct factor Xa inhibitor indicated for prevention of stroke / systemic embolism in adult patients with NVAF, with one or more risk factors (such as prior stroke or transient ischaemic attack, age ≥ 75 years, hypertension, diabetes mellitus, symptomatic heart failure [New York Heart Association Class ≥ II]), treatment of DVT and PE, and prevention of recurrent DVT and PE in adults.1


  1. ELIQUIS® (apixaban) Summary of Product Characteristics.